| The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012. | |
| | |
MedLine Citation:
|
PMID: 23217418 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
During Q2-Q3 2012, the cell therapy industry benefited from a number of positive external influences including advantageous changes to future FDA regulation, but stock market activity was highly mixed. The FDA approved two more products and an appreciable number of public-company-sponsored clinical trials are progressing through phases 1-3. |
| | |
Authors:
|
Chris Mason; Mark J McCall; Emily J Culme-Seymour; Shalini Suthasan; Simon Edwards-Parton; Gregory A Bonfiglio; Brock C Reeve |
Related Documents
:
|
21192768 - Awareness and implementation of the 2000 united states public health service tobacco de... 21861918 - The public goods hypothesis for the evolution of life on earth. 437698 - The synthesis of a new phospholipid from the koilin glandular layer of chicken gizzard. 23132638 - Anaesthetic preference and outcomes for elective inguinal hernia repair: a comparative ... 12461838 - Disabilities secondary to traffic accidents: what information is available in belgium? 23651528 - Raymond gosling: the man who crystallized genes. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cell stem cell Volume: 11 ISSN: 1875-9777 ISO Abbreviation: Cell Stem Cell Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101311472 Medline TA: Cell Stem Cell Country: United States |
Other Details:
|
Languages: eng Pagination: 735-9 Citation Subset: IM |
Copyright Information:
|
Copyright © 2012 Elsevier Inc. All rights reserved. |
Affiliation:
|
The Advanced Centre for Biochemical Engineering, University College London, Torrington Place, London, WC1E 6BT, UK. Electronic address: chris.mason@ucl.ac.uk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Utf1: Goldilocks for ESC Bivalency.
Next Document: Nuclear cloning and direct reprogramming: the long and the short path to stockholm.